Component:
The artificial intelligence in cancer diagnostics market can be segmented by component into software, hardware, and services. Software segment is expected to dominate the market due to the increasing adoption of AI-powered software for analyzing medical imaging, genomic data, and clinical data for accurate cancer diagnosis.
Cancer Type:
In terms of cancer type, the market can be segmented into breast cancer, lung cancer, prostate cancer, colorectal cancer, and others. Breast cancer segment is anticipated to lead the market as it is one of the most common types of cancer among women worldwide. AI technologies are being increasingly used for early detection and personalized treatment of breast cancer.
End-user:
The artificial intelligence in cancer diagnostics market can also be segmented by end-user into hospitals, diagnostic centers, research institutes, and others. Hospitals are likely to be the major end-users of AI in cancer diagnostics due to the high patient footfall and the need for accurate and timely cancer diagnosis and treatment. Research institutes are also expected to contribute significantly to market growth through ongoing research and development activities in the field of AI-powered cancer diagnostics.